Marksans Pharma Quarterly Results for Trading Insights
MARKSANS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹99 Cr
QSept 2025
Marksans Pharma Quarterly Results Key Highlights
- Revenue of ₹742 Cr in Sept 2025 (+2.5% vs Mar 2025, +15.6% vs Sept 2024)
- Net Profit of ₹99 Cr in Sept 2025 (+8.8% vs Mar 2025, +1.0% vs Sept 2024)
- EBITDA of ₹166 Cr in Sept 2025 (+16.9% vs Mar 2025)
- Operating Margin of 20.0% in Sept 2025 (+2.0pp vs Mar 2025)
- Earnings Per Share of ₹2.17 in Sept 2025 (+8.5% vs Mar 2025)
Marksans Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 742 | 724 | 626 | 775 | 642 | 2.5% | 15.6% |
| Net Profit (₹ Cr) | 99 | 91 | 58 | 114 | 98 | - | - |
| EBITDA (₹ Cr) | 166 | 142 | 106 | 181 | 147 | - | - |
| EPS (₹) | 2.17 | 2.00 | 1.29 | 2.50 | 2.13 | - | - |
| Operating Margin (%) | 20.0% | 18.0% | 16.0% | 21.0% | 23.0% | - | - |
Marksans Pharma Share Price Trend Around Quarterly Results
Visualize Marksans Pharma's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.
Related Pages for Marksans Pharma
Additional stock information and data for MARKSANS
Revenue Trend (₹ Cr)
Dec 2025
775
Jun 2025
626
Mar 2025
724
Sept 2025
742
Net Profit Trend (₹ Cr)
Dec 2025
114
Jun 2025
58
Mar 2025
91
Sept 2025
99
Operating Margin Trend (%)
Dec 2025
21.0%
Jun 2025
16.0%
Mar 2025
18.0%
Sept 2025
20.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Marksans Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹406,351.37 Cr | 1718.0 | 14,875 | 3,125 | +10.8% | - | 21.0% | 132.2 |
|
Divis Laboratories
Sept 2025 |
₹155,471.67 Cr | 5850.0 | 2,860 | 689 | +7.1% | - | 24.1% | 225.3 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹134,945.00 Cr | 4051.3 | 3,219 | 591 | +11.3% | - | 18.4% | 231.0 |
|
Lupin
Sept 2025 |
₹102,578.78 Cr | 2298.3 | 6,921 | 1,485 | +23.2% | - | 21.5% | 71.0 |
|
Dr Reddys Laborator…
Sept 2025 |
₹101,601.09 Cr | 1196.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 73.9 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores